Hemodialysis and Peritoneal Dialysis Market Boosted by Renal Disorders

The global hemodialysis and peritoneal dialysis market was valued at USD 102.1 billion in 2023 and is projected to reach USD 185.88 billion by 2030, expanding at a CAGR of 9.1% from 2024 to 2030. Growth in this market is primarily driven by the shortage of organ donors, increasing incidence of acute kidney injury (AKI), risks associated with kidney transplantation, technological advancements, and strategic initiatives by major industry players to introduce innovative dialysis products and services.

Key Market Trends & Insights

  • North America held the largest revenue share of 38.25% in 2023.
  • Asia Pacific is expected to record the fastest CAGR during the forecast period.
  • Hospital-based end-use segment led the market with 76.75% revenue share in 2023.
  • Service segment dominated the product category with a 56.61% share in 2023.
  • Hemodialysis accounted for the highest share of 82.71% in 2023.

Market Size & Forecast

  • 2023 Market Size: USD 102.1 Billion
  • 2030 Projected Market Size: USD 185.88 Billion
  • CAGR (2024–2030): 9.1%
  • North America: Largest market in 2023
  • Asia Pacific: Fastest-growing market

Chronic kidney disease (CKD) caused by impaired kidney function often progresses into End-Stage Renal Disease (ESRD), thereby increasing the need for dialysis. Rising CKD prevalence is expected to contribute significantly to the demand for dialysis treatments and equipment.

According to the CDC’s 2023 report, CKD affects approximately 35.5 million individuals in the U.S. annually. Additionally, the National Institute of Diabetes and Digestive and Kidney Diseases (2022) reported that 25,499 kidney transplant procedures were performed in the U.S., indicating transplant dependency and the ongoing need for dialysis support.

Order a free sample PDF of the Hemodialysis And Peritoneal Dialysis Market Intelligence Study, published by Grand View Research.

Key Companies & Market Share Insights

Major players are prioritizing new product development, regulatory approvals, expansion strategies, partnerships, acquisitions, and investments in R&D. For example, in April 2023, Outset Medical, Inc. advanced its Tablo Hemodialysis System to reduce dialysis complexity and cost. The company presented five new clinical and economic abstracts at the National Kidney Foundation Spring Clinical Meetings, supporting improved home hemodialysis outcomes and addressing gender bias in nephrology.

Key Hemodialysis and Peritoneal Dialysis Companies

  • Baxter
  • Braun SE
  • Fresenius Medical Care AG
  • Medtronic
  • Asahi Kasei Medical Co., Ltd.
  • Nipro Corp.
  • DaVita
  • BD
  • Nikkiso Co., Ltd.
  • Cantel Medical

Conclusion

The hemodialysis and peritoneal dialysis market is experiencing robust growth due to increasing CKD and ESRD prevalence, rising AKI cases in both adults and infants, and the expanding diabetic and hypertensive population. Innovations in dialysis technology, coupled with significant strategic initiatives from major market players, are accelerating product adoption globally. With North America leading and Asia Pacific showing the fastest expansion, the market is set to experience strong long-term demand for advanced dialysis solutions.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Urodynamic Equipment and Consumables Market Forecast: Anticipating Future Innovations

  The global urodynamic equipment and consumables market size is expected to reach USD 449.2 million in 2030 and is projected to grow at a CAGR of 5.7% from 2024 to 2030. This market is anticipated to grow at an unprecedented rate owing to growing geriatric population that exhibits greater vulnerability to urological dysfunctions. In addition, unprecedented upsurge in prevalence of bladder cancer poses high clinical urgency to adopt highly efficient diagnostics, which thereby broadens future growth prospects. In 2017, as per the American Cancer Society, bladder cancer accounted for 5.0% of all cancers in the U.S. The market is also driven by global increase in obesity. As per the Centers for Disease Control and Prevention, approximately 36.0% of adult population is obese. According to a research published in NCBI, obesity has increased the risk of developing various urological conditions, such as prostate cancer, nephrolithiasis, hypogonadism, and urinary tract infections. Furtherm...
Read more

Mobile Device Management Market Thrives with Growth in Cloud-Based Solutions

  According to a recent report by Grand View Research, Inc., the global   mobile device management (MDM) market   is projected to reach USD 28.37 billion by 2030, expanding at a CAGR of 24.5% from 2025 to 2030. This growth is primarily attributed to the increasing use of mobile devices in the workplace and the growing need to manage and secure them effectively. As smartphones, tablets, and other mobile devices become more prevalent, employees are increasingly using their personal devices for work—an approach known as Bring Your Own Device (BYOD). This trend is contributing to the rising number of mobile devices requiring centralized oversight and protection. MDM solutions offer organizations a unified platform to oversee and secure mobile devices, enabling functions such as security policy enforcement, device usage monitoring, and remote data wiping in cases of loss or theft. As companies continue to implement BYOD strategies or issue corporate devices to employees, deman...
Read more

U.S. Interventional Oncology Market Boosted by Aging Population

  The   U.S. interventional oncology market   size was estimated at USD 998.4 million in 2024 and is projected to reach USD 1,597 million by 2030, expanding at a CAGR of 8.17% from 2025 to 2030. This market growth is primarily driven by the increasing prevalence of cancer, continuous technological advancements in minimally invasive treatments, expanding investments in interventional oncology, and the aging population across the U.S. A major contributing factor is the rising incidence of cancer in the country. According to the American Cancer Society, approximately 2,041,910 new cancer cases are expected to be diagnosed in the U.S. in 2025, with 618,120 projected cancer-related deaths. As conventional therapies like chemotherapy and radiation often lead to significant side effects, minimally invasive techniques such as radiofrequency ablation and microwave ablation are becoming more popular. These procedures target tumors precisely while minimizing harm to surrounding tiss...
Read more